Clinical Trial Update: Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing adjuvant gemcitabine alone versus gemcitabine with chemoradiation after R1 resection or positive lymph nodes in pancreatic adenocarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pancreatic Neoplasms | Phase 2 | Status: UNKNOWN